Evidence map›Paper›PMID 33130560›Full record

ArticleBMJ open2020

Primary care practitioners' diagnostic action when the patient may have cancer: an exploratory vignette study in 20 European countries.

Michael Harris, Mette Brekke, Geert-Jan Dinant, Magdalena Esteva, Robert Hoffman, Mercè Marzo-Castillejo, Peter Murchie, Ana Luísa Neves, Emmanouil Smyrnakis, Peter Vedsted and 16 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. How do the UK's guidelines on imaging for suspected lung cancer compare with other countries?The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Michael HarrisDepartment for Health, University of Bath, Bath, Somerset, UK michaelharris681@btinternet.com.ORCID 0000-0002-7166-2971
Mette BrekkeDepartment of General Practice and General Practice Research Unit, University of Oslo, Oslo, Norway.ORCID 0000-0003-3454-2329
Geert-Jan DinantDepartment of General Practice, Maastricht University, Maastricht, The Netherlands.
Magdalena EstevaBalearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Illes Balears, Spain.
Robert HoffmanDepartment of Family Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-3053-835X
Mercè Marzo-CastillejoUnitat de Suport a la Recerca Costa de Ponent, IDIAP Jordi Gol, Barcelona, Spain.
Peter MurchieDivision of Applied Health Science, University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-9968-5991
Ana Luísa NevesCentre for Health Policy, Imperial College London, London, UK.
Emmanouil SmyrnakisLaboratory of Primary Health Care, General Practice and Health Services Research, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Peter VedstedResearch Unit for General Practice, University of Aarhus, Aarhus, Denmark.
Isabelle Aubin-AugerDepartment of General Practice, Université Paris Diderot, Paris, Île-de-France, France.
Joseph AzuriSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Krzysztof BuczkowskiDepartment of Family Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
Nicola BuonoDepartment of Family Medicine, National Society of Medical Education in General Practice (SNaMID), Prata Sannita, Italy.ORCID 0000-0001-8797-477X
Gergana ForevaMedical Center BROD, Plovdiv, Bulgaria.
Svjetlana Gašparović BabićCroatian Health Insurance Fund, Rijeka, Croatia.
Eva JacobPrimary Health Centre, Centro de Saúde Sarria, Sarria, Lugo, Spain.
Tuomas KoskelaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Davorina PetekDepartment of Family Medicine, Univerza v Ljubljani, Ljubljana, Slovenia.
Marija Petek ŠterDepartment of Family Medicine, Univerza v Ljubljani, Ljubljana, Slovenia.
Aida PuiaFamily Medicine Department, Iuliu Hagieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Jolanta Sawicka-PowierzaDepartment of Family Medicine, Uniwersytet Medyczny w Bialymstoku, Bialystok, Poland.ORCID 0000-0002-0860-2554
Sven StreitInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.ORCID 0000-0002-3813-4616
Hans ThulesiusDepartment of Research and Development, Lund University, Malmö, Sweden.
Birgitta WeltermannInstitut für Hausarztmedizin, University of Bonn, Bonn, Nordrhein-Westfalen, Germany.
Gordon TaylorCollege of Medicine and Health, University of Exeter, Exeter, Devon, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCancer survival rates vary widely between European countries, with differences in timeliness of diagnosis thought to be one key reason. There is little evidence on the way in which different healthcare systems influence primary care practitioners' (PCPs) referral decisions in patients who could have cancer.This study aimed to explore PCPs' diagnostic actions (whether or not they perform a key diagnostic test and/or refer to a specialist) in patients with symptoms that could be due to cancer and how they vary across European countries.

designA primary care survey. PCPs were given vignettes describing patients with symptoms that could indicate cancer and asked how they would manage these patients. The likelihood of taking immediate diagnostic action (a diagnostic test and/or referral) in the different participating countries was analysed. Comparisons between the likelihood of taking immediate diagnostic action and physician characteristics were calculated.

settingCentres in 20 European countries with widely varying cancer survival rates.

participantsA total of 2086 PCPs answered the survey question, with a median of 72 PCPs per country.

resultsPCPs' likelihood of immediate diagnostic action at the first consultation varied from 50% to 82% between countries. PCPs who were more experienced were more likely to take immediate diagnostic action than their peers.

conclusionWhen given vignettes of patients with a low but significant possibility of cancer, more than half of PCPs across Europe would take diagnostic action, most often by ordering diagnostic tests. However, there are substantial between-country variations.

Indexed as

NeoplasmsPhysicians, Primary CareEuropeHumansPrimary Health CareReferral and ConsultationSurvival Rateadult oncologyinternational health servicesprimary care

Identifiers

PMID33130560
PMCPMC7783622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.